Pavilion Capital Partners

Lhoopa is a property technology company focused on transforming the affordable housing landscape in emerging markets. By utilizing data-driven insights and innovative approaches, Lhoopa collaborates with local partners to facilitate the development of affordable homes, effectively tackling the pressing housing shortages in these regions. The company operates within the real estate sector, assisting various partners and clients in navigating property transactions, from raw land to developed properties and rental markets. Lhoopa emphasizes customization to meet the unique needs of its partners, aiming to enhance profitability and foster sustainable growth in the real estate market.

Rebellions.ai is a developer of artificial intelligence semiconductor-based solutions focused on creating AI accelerators that connect core semiconductor architectures with deep learning algorithms. The company aims to deliver domain-specific AI processors alongside optimized software, effectively bridging the gap between silicon technology and advanced AI applications. By re-architecting AI processors to integrate specialized deep learning kernels, Rebellions enables clients to utilize energy-efficient AI hardware that seamlessly integrates into their operations. This approach allows clients to maximize the potential of their silicon resources while enhancing performance in AI-driven tasks.

Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

EcoSpirits is a company focused on creating a closed-loop distribution system aimed at minimizing packaging waste within the premium spirits supply chain. It has developed innovative technology that includes a fully reusable, tamper-proof, and shock-proof glass vessel, alongside a semi-automated facility for sanitizing, refilling, and sealing spirits. This approach not only significantly reduces packaging and transport costs for businesses but also leads to a substantial reduction in carbon footprints. By streamlining the distribution process, EcoSpirits offers a sustainable alternative that benefits both the environment and the bottom line.

Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

Flare Therapeutics is a biotechnology company dedicated to developing small molecule medicines through a novel approach to understanding transcription factors. By identifying 'switch sites,' which are druggable regions crucial for regulating transcription factors, Flare aims to target mutations that lead to various diseases. The company has rapidly advanced its drug discovery efforts, creating an emerging pipeline of programs initially focused on precision oncology. Additionally, Flare's innovative platform holds promise for addressing conditions in neurology, rare genetic disorders, immunology, and inflammation, ultimately enabling medical professionals to transform treatment strategies for patients.

Medigo is a telehealth platform that specializes in providing on-demand medicine prescription and delivery services. The platform is equipped with a 24/7 quick medicine delivery service that guarantees customers receive their medication as quickly as possible within 20 minutes, even during emergencies. Additionally, Medigo offers home testing services that allow customers to perform various health tests in the comfort of their own homes, such as blood tests, urine tests, and pregnancy tests. Through its digital transformation initiatives, the platform strives to optimize its operations and enhance the mental and physical well-being of the community.

JNPMEDI is a company focused on advancing the Korean medical infrastructure through a specialized medical data platform. It develops solutions that facilitate clinical research and trial operations, offering digital alternatives that enhance the capabilities of regulatory authorities, pharmaceutical companies, and clinical research organizations. By providing tools that help healthcare professionals execute, manage, monitor, and audit clinical trials, JNPMEDI aims to transform the clinical research landscape, ensuring efficiency and compliance in medical studies.

Vow Foods is a company that specializes in producing cultivated exotic meat through lab-based methods. By utilizing animal cells rather than traditional livestock, Vow aims to create sustainable and ethical meat alternatives. The process involves harvesting animal cells via biopsy and growing them in a nutrient-rich medium, which allows for the development of a diverse range of meat products. This innovative approach not only provides consumers, restaurants, and chefs with nutritious and flavorful options but also reduces reliance on natural resources typically used in conventional meat production.

Starfire Energy is a company focused on developing and deploying sustainable energy technologies, specializing in the production of carbon-free ammonia. Founded in 2007 and headquartered in Aurora, Colorado, Starfire Energy has created modular systems that synthesize ammonia from renewable energy sources, specifically wind and solar power. These modular plants are built in shipping containers that are pre-wired and pre-plumbed, facilitating easy on-site installation. The ammonia produced is not only used as a fertilizer and refrigerant but also serves as an energy-dense liquid fuel. By utilizing renewable energy, air, and water as inputs, Starfire Energy aims to meet the growing demands for energy storage and transportation while contributing to carbon-free industrial processes.

LevitasBio specializes in cellular analytics through its innovative platform that employs magnetic levitation technology. This approach addresses the limitations of traditional cellular analysis by offering label-free and universal methods for studying high-value primary samples and sensitive cell types. The company's LeviCell platform enables scientists to purify cells and nuclei without the need for markers or modifications, allowing for the examination of biological signatures while preserving the integrity of the original samples. By facilitating a deeper and more accurate understanding of biological processes, LevitasBio aims to advance research in the life sciences and healthcare sectors.

Asuene is a company focused on renewable power retail services that facilitate local production and consumption of energy. Additionally, it has developed a carbon management platform aimed at assisting organizations in tracking, managing, and reporting their greenhouse gas emissions and other environmental impacts. Utilizing artificial intelligence, the platform integrates various data sources to collect emissions information and formulate strategies for reducing pollutants over time. This enables organizations to effectively manage their environmental footprint, comply with regulatory requirements, and work towards their sustainability objectives.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

MoMa Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2019. The company specializes in discovering precision medicines by targeting the molecular machines that are fundamental to human disease. Formerly known as ATPases NewCo, Inc., MoMa Therapeutics utilizes a unique platform that leverages the shared characteristics of ATPase enzymes, including their large-scale conformational changes and energy-driven mechanics. By integrating advances in structural biology and small-molecule drug discovery, MoMa Therapeutics aims to develop therapies targeting this previously challenging class of enzymes, thereby advancing the field of precision medicine.

RVAC Medicines is an innovative mRNA platform company founded in 2021 and based in Singapore. The company focuses on developing a diverse pipeline of novel mRNA vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. RVAC Medicines offers end-to-end GMP manufacturing capabilities and maintains infrastructure for process scale-up and technology transfer. Its research and development efforts, combined with external partnerships, facilitate the creation of advanced mRNA and nucleic acid delivery technologies. The company's mission is to empower healthcare professionals in tackling infectious diseases through its cutting-edge solutions.

Swatch On operates a fabric marketplace designed to facilitate reliable fabric sourcing for fashion designers. Launched with the goal of offering a diverse selection of unique, high-quality wholesale fabrics at competitive prices, Swatch On has developed a comprehensive database of fabrics sourced from Dongdaemun. The company prides itself on its team of young, creative, and motivated professionals who are passionate about fashion fabric. Their personalized approach ensures that clients receive tailored assistance in finding the perfect materials for their collections, enhancing the overall experience of sourcing fabrics for design projects.

ENSEM Therapeutics is a pioneering drug discovery and development company focused on creating innovative small-molecule precision medicines for oncology. Utilizing its proprietary Kinetic Ensemble platform, the company specializes in detecting and characterizing rare conformational states of drug targets, which are crucial for understanding oncogenic processes, regulatory mechanisms, and drug resistance. This approach not only provides new therapeutic opportunities but also allows drug developers to address high-value targets that are typically challenging to target. With potential applications extending beyond oncology to genetic disorders and other disease areas, ENSEM Therapeutics aims to transform the landscape of precision medicine.

Synspective Inc., headquartered in Tokyo, Japan, specializes in providing data solutions by leveraging synthetic aperture radar (SAR) satellite constellations, big data, and machine learning. The company serves a variety of markets, including urban design, infrastructure, energy, insurance, finance, and government agencies. Synspective offers remote monitoring services and satellite imagery using small-sized SAR satellites, which can measure human activity over wide areas on Earth, unaffected by time or weather conditions. This technology supports clients in achieving sustainable development and resilient urban development goals.

ArkEdge Space is a manufacturer of microsatellites aimed at promoting space development and usage. The company develops and tests an ultra-small spacecraft that is responsible for communication and positioning systems for lunar activities, as well as establishes a method for cost reduction and mass production of high-performance 6U satellites, allowing businesses in positioning and communication technology to benefit the community by meeting their space needs.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

UrBox is a prominent electronic gift company based in Vietnam, specializing in digitized rewards and e-vouchers. With a network of over 3,000 suppliers, UrBox connects businesses with various gift and loyalty program providers, facilitating efficient implementation of marketing strategies. The company's platform allows businesses to streamline their gift programs, helping them save time and resources while enhancing customer engagement and satisfaction. UrBox enables consumers to easily redeem their gifts both online and offline, making it a versatile solution in the rewards industry.

Space BD is a provider of space-related services that focuses on facilitating the industrialization of space. The company aims to serve as a comprehensive resource for businesses developing new technologies, helping them navigate challenges in the commercialization of low Earth orbit. By adopting a business-driven approach, Space BD seeks to simplify access to space for scientists and organizations, thereby promoting innovation and growth in the space sector.

HotSpot Therapeutics is a biotechnology startup based in Boston, Massachusetts, established in 2017. The company specializes in the development of allosteric therapies that target regulatory sites on proteins. Its innovative therapeutic platform is designed to identify hotspots and locate pathway treatments for cancer, metabolic disorders, and rare diseases. By leveraging a comprehensive database of hotspot structures and utilizing data science, HotSpot Therapeutics employs a multidisciplinary approach to drug discovery. This approach aims to enhance the effectiveness of treatments and improve patient outcomes across a range of conditions.

Hepmil Media Group is a technology-driven media company based in Southeast Asia that focuses on enhancing the lives of millions through engaging and entertaining content. It operates a media service platform designed to connect internet influencers with corporate clients. By partnering with content creators who possess substantial followings on various content-sharing platforms, Hepmil facilitates marketing activities that leverage the influence of these internet celebrities. The company offers localization and strategic direction to brands, ensuring effective collaboration between influencers and corporate partners. Through its innovative approach, Hepmil aims to create meaningful connections that benefit both content creators and businesses.

Linc'well Inc., founded in 2018 and based in Tokyo, Japan, is a healthcare technology company that develops a software as a service (SaaS) platform tailored for the healthcare industry. The platform offers various digital services including web inquiries, call handling, payment processing, electronic medical records management, and other digitization solutions. Additionally, Linc'well provides clinic operation and management support through its brand CLINIC FORE, along with online support services such as medical supplement subscriptions. These offerings are designed to enhance the efficiency of healthcare institutions and clinics by improving operational processes and patient experiences.

Infinium is an electrofuels provider that specializes in creating synthetic fuels from renewable energy and waste carbon dioxide. The company focuses on manufacturing ultra-low carbon electrofuels, which serve as drop-in replacements for traditional petroleum-derived products, allowing clients to significantly reduce harmful greenhouse gas emissions in the transportation sector. Infinium's solutions not only contribute to decarbonizing transportation but also provide lower carbon alternatives for various chemical processes, including plastics production. By utilizing existing transportation systems, Infinium enables immediate impacts on carbon reduction targets without the need for capital- and time-intensive upgrades.

Accredify is a Singapore-based company specializing in the creation and issuance of verifiable digital documents for organizations across various sectors. With a presence in over nine markets and a client base of 900 globally, Accredify has facilitated nearly 7 million verifications of its documents. The company's cloud-based system ensures that all issued documents are tamper-proof and traceable, allowing users to verify them through a simple drag-and-drop process. Initially focused on the higher education sector, Accredify has since expanded into healthcare, notably contributing to the development of Singapore's HealthCerts, which provide digitally verifiable COVID-19 test results. Recognized internationally, these certificates can be validated via QR codes and are accepted in over 32 countries. Accredify also offers a suite of APIs for seamless integration, enabling organizations to automate the issuance of verifiable digital credentials. With a commitment to customer service, security, and legal compliance, Accredify aims to be a trusted solution for document management and verification.

Allay Therapeutics is focused on developing innovative solutions for post-surgical pain management, aiming to enhance patient recovery experiences. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutics. These products are designed to deliver targeted pain relief over extended periods, significantly surpassing the duration of existing pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical study for total knee arthroplasty surgeries. With a diverse team of entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics seeks to address the limitations of conventional pain management approaches, particularly the challenges associated with opioid use.

Founded in 2013, Hydrogenious Technoloiges is a spin-off of the University of Erlangen-Nuremberg by its CEO Dr. Daniel Teichmann and the three co-founders Prof. Wolfgang Arlt, Prof. Peter Wasserscheid and Prof. Eberhardt Schlücker. The need for safe and efficient hydrogen storage for multi-MWh energy storage systems and safe and reliable hydrogen storage for hydrogen refuelling stations and fuel cell mobility was imminent – and Liquid Organic Hydrogen Carriers (LOHC) proved to be the solution. Having completed the technological proof of concept at the university’s laboratories, the idea became reality and Hydrogenious Technologies, a global pioneer in LOHC based energy storage, was born. With the University of Erlangen-Nuremberg becoming a shareholder in May 2014 and the successful close of a Series A funding round in July 2014 with Anglo American Platinum as investor, Hydrogenious Technologies is now backed with strong scientific, strategic and financial capacities to revolutionize large-scale energy and hydrogen storage.

Atama plus Inc. is an educational technology and SaaS startup based in Minato-ku, Tokyo, Japan, founded in 2017. The company specializes in providing AI-driven personalized learning programs for elementary, middle, and high school students. By analyzing various data points, including learning history, proficiency levels, concentration levels, and tendencies to forget, Atama plus designs adaptive learning experiences tailored to individual student needs. This approach aims to help students acquire fundamental academic skills efficiently while also fostering their ability to apply these skills in real-world contexts.

Pivot Bio, Inc. is a biotechnology company founded in 2010 and based in Emeryville, California. The company focuses on enhancing crop nutrition through a deep understanding of the microbiome, utilizing engineered microbes to deliver essential nutrients, protect against pests, and improve crop quality. By leveraging data science and engineering principles, Pivot Bio aims to map the dynamics of the plant microbiome and develop beneficial traits. Their proprietary ON Technology utilizes naturally occurring microbes to supply nitrogen to crops, offering a sustainable alternative to synthetic fertilizers. This innovation not only helps farmers increase yields but also contributes to reducing reliance on petrochemical fertilizers, ultimately promoting healthier ecosystems and cleaner air and water. Pivot Bio's current initiatives primarily focus on enabling microbes to fix and supply nitrogen for corn, addressing the growing need for sustainable agricultural practices as the global population expands.

OY! is a fintech application based in Jakarta, Jakarta Raya, that was co-founded in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus. The company specializes in simplifying financial management through its digital payment portal, which allows users to transfer money directly from debit cards, view bank account balances, and access bank statements. OY! aims to streamline financial transactions by integrating various payment functionalities into a single platform, helping clients achieve financial wellness and save time. By offering these services for free, OY! enhances the accessibility and efficiency of personal finance management for its users.

Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

KAHR Medical Ltd., established in 2005 and headquartered in Jerusalem, Israel, is a biopharmaceutical company specializing in immuno-oncology drug development. It focuses on creating fusion protein pharmaceuticals for treating cancer and autoimmune diseases. KAHR's proprietary technology involves developing 'third generation biological drugs,' which are unique fusion-protein molecules designed to activate immune responses by converting cancer cells' protective mechanisms into targets for the immune system. The company offers several candidates, including DSP105 and DSP106 for T-cell mediated tumor destruction, and DSP107 targeting CD47 tumors while delivering an immune costimulatory signal.

Super Studio is a technology company that offers research, development, operation, and maintenance of software solutions tailored for direct-to-consumer (D2C) operations. They specialize in improving efficiency through SaaS services focused on product planning, manufacturing, sales promotion, supply chain optimization, CRM after-sales support, and enterprise collaboration platforms for sales and marketing teams.

NiKang Therapeutics, Inc. is a biotechnology company established in 2017 and headquartered in Wilmington, Delaware. The company specializes in the discovery and development of small molecule oncology medicines aimed at addressing unmet medical needs in cancer treatment. Utilizing a discovery approach informed by target structure biology, NiKang employs structure-based drug design to facilitate the rapid and efficient development of proprietary drug candidates. This methodology enables the company to create innovative therapies with desirable pharmacological properties, ultimately aimed at improving the lives of patients through enhanced treatment options.

Inari is a biotechnology company focused on revolutionizing agriculture and its societal and environmental impact. The company utilizes advanced technologies, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its unique SEEDesign platform distinguishes Inari by enabling the enhancement of various crops across different geographies, facilitating the development of innovative agricultural products. By embracing diversity, Inari fosters innovation and aims to contribute to the creation of a new food system.

Blind is an anonymous professional network designed to facilitate open communication among verified professionals across various industries. With over 4.1 million users worldwide, the platform enables individuals to engage in private company channels with colleagues and participate in open forums for broader discussions. Users can share valuable insights, such as job offer details and honest feedback about company culture, without fear of judgment or retribution. Blind aims to promote transparency in the workplace, empowering professionals to make informed decisions and encouraging meaningful change within their organizations.

Studist is a startup focused on enhancing information transmission within enterprises through its manual creation and sharing platform, Teachme Biz. This platform enables users to create standard work procedure manuals by integrating images and videos with descriptive text, facilitating an intuitive and efficient process for information sharing. By streamlining the creation and management of business manuals, Studist aims to minimize the loss of critical information among employees, ultimately fostering a work environment where intellectual vitality is fully harnessed and visible.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

PT. SiCepat Ekspres Indonesia is a logistics company established in 2004 and headquartered in Jakarta Pusat, Indonesia. The company specializes in courier delivery services throughout Indonesia, providing a range of logistics and shipping solutions. Its offerings include freight forwarding, warehousing, parcel courier, consignment, and delivery services. SiCepat Ekspres aims to facilitate trade in emerging markets by ensuring the timely movement of shipments, thereby supporting businesses in their growth and operational efficiency.

ScaleFlux, Inc. is a semiconductor company specializing in data flow architecture and computational storage solutions. Founded in 2014 and headquartered in San Jose, California, with additional offices in Beijing, Shanghai, and Hangzhou, the company focuses on enhancing the efficiency of data centers and cloud infrastructures tailored for data-intensive applications. ScaleFlux's innovative products are designed to give users a competitive advantage by optimizing the data pipeline for cloud, artificial intelligence, enterprise, and edge computing. The company's offerings include advanced storage and memory systems that combine compute engines with substantial solid-state storage, facilitating improved performance, efficiency, security, and scalability. To support customer adoption, ScaleFlux provides fully validated firmware, software, and module designs, in addition to its own branded modules, ensuring seamless integration into existing systems.

Waresix is a logistics platform based in Jakarta, Indonesia, that specializes in freight forwarding, warehousing, and land transportation. The platform facilitates the connection between business owners and professional warehouse operators, allowing users to access on-demand warehouse services. Waresix addresses the growing demand for flexible warehousing solutions, particularly in the expanding e-commerce market. By matching unused warehouse space with businesses in need, the platform enables clients—including retailers, distributors, and manufacturers—to effectively manage inventory, adapt to variable demand, and streamline operations through features such as documentation management and billing.

Sociolla is an online beauty and personal care shopping platform based in Indonesia, focused on providing a wide range of authentic cosmetics, skincare, haircare, beauty equipment, and perfumes. Established to create a comfortable and reliable shopping experience for women, Sociolla partners exclusively with authorized distributors and brand holders to ensure the authenticity and quality of its products. The platform features an extensive selection of items, including lip gloss, serums, lipsticks, eyeshadow palettes, hair oils, face masks, and perfumes, all available for home delivery. By prioritizing product quality, Sociolla aims to meet the beauty needs of its customers effectively.

Pivot Bio, Inc. is a biotechnology company founded in 2010 and based in Emeryville, California. The company focuses on enhancing crop nutrition through a deep understanding of the microbiome, utilizing engineered microbes to deliver essential nutrients, protect against pests, and improve crop quality. By leveraging data science and engineering principles, Pivot Bio aims to map the dynamics of the plant microbiome and develop beneficial traits. Their proprietary ON Technology utilizes naturally occurring microbes to supply nitrogen to crops, offering a sustainable alternative to synthetic fertilizers. This innovation not only helps farmers increase yields but also contributes to reducing reliance on petrochemical fertilizers, ultimately promoting healthier ecosystems and cleaner air and water. Pivot Bio's current initiatives primarily focus on enabling microbes to fix and supply nitrogen for corn, addressing the growing need for sustainable agricultural practices as the global population expands.

Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.

KAHR Medical Ltd., established in 2005 and headquartered in Jerusalem, Israel, is a biopharmaceutical company specializing in immuno-oncology drug development. It focuses on creating fusion protein pharmaceuticals for treating cancer and autoimmune diseases. KAHR's proprietary technology involves developing 'third generation biological drugs,' which are unique fusion-protein molecules designed to activate immune responses by converting cancer cells' protective mechanisms into targets for the immune system. The company offers several candidates, including DSP105 and DSP106 for T-cell mediated tumor destruction, and DSP107 targeting CD47 tumors while delivering an immune costimulatory signal.

GudangAda is a developer of a business-to-business (B2B) marketplace focused on transforming and digitalizing Indonesia's distribution chain for fast-moving consumer goods. The company connects key stakeholders, including principals, distributors, wholesalers, and retailers, through an end-to-end digital solution. Its platform allows users to meet and conduct transactions online, supporting both small and bulk orders. By facilitating these transactions, GudangAda enables traders to operate as both sellers and buyers simultaneously, which enhances turnover, reduces costs, and expands customer reach. The company also offers logistics, merchant solutions, and financial services, contributing to the efficiency and effectiveness of the supply chain within the marketplace.

OY! is a fintech application based in Jakarta, Jakarta Raya, that was co-founded in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus. The company specializes in simplifying financial management through its digital payment portal, which allows users to transfer money directly from debit cards, view bank account balances, and access bank statements. OY! aims to streamline financial transactions by integrating various payment functionalities into a single platform, helping clients achieve financial wellness and save time. By offering these services for free, OY! enhances the accessibility and efficiency of personal finance management for its users.

ReadCoor, Inc. is a technology company based in Cambridge, Massachusetts, specializing in the development and commercialization of a panomic spatial sequencing platform. The company offers the RC2 Platform, which utilizes proprietary Fluorescent in situ Sequencing (FISSEQ) technology to enable researchers, clinicians, and pharmaceutical and diagnostics companies to perform multi-omic analyses. This platform allows for the simultaneous detection and sequencing of numerous RNA, DNA, proteins, and therapeutics while visualizing sub-cellular nanoscale 3D resolution across tissue sections. By integrating high throughput sequencing with morphometric analysis and three-dimensional spatial imaging, ReadCoor provides valuable insights into human biology, facilitating the development of new therapeutics for various conditions, including cancer, infectious diseases, and neurological disorders. Founded in 2016, ReadCoor operates as a subsidiary of 10x Genomics, Inc. as of October 2020.

Appier Inc., established in 2012 and headquartered in Taipei, Taiwan, specializes in providing AI-powered platforms for enterprises worldwide. Its suite of products includes Aideal for driving purchase decisions, AIQUA for proactive customer engagement, AIXON for unified data science, and CrossX for AI-driven advertising solutions. Appier serves approximately 1,000 global brands and agencies across Asia from its offices in 14 markets, helping businesses make data-driven decisions to increase customer engagement and predict user behavior without the need for specialized AI engineers.

Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.

Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.

Advance Intelligence Group is a financial technology firm that builds an ecosystem of AI-powered, credit-enabled products, and services. Founded in 2016, it leverages innovative technology and partnerships to build an ecosystem of products and services serving consumers, enterprises, and merchants.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Edmicro is a Vietnamese education technology company established in 2018, headquartered in Hanoi. It specializes in developing an online learning platform for students, featuring Onluyen, a cloud-computing system offering personalized learning paths, virtual classrooms, digital libraries, smart reports, microlearning modules, and assessment tools. The platform automates resource creation, aligns content with learning objectives, and adapts to each learner's profile and knowledge gaps, tracking performance and predicting development. It provides an extensive range of tracks and microlessons tailored to Vietnamese students' classroom subjects.

CyCraft is a cybersecurity solutions provider that specializes in securing national governments, Fortune 500 companies, and small to medium enterprises. The company has developed an advanced artificial intelligence platform known as CyCraft AIR, which has been recognized for its effectiveness in enhancing cybersecurity resilience. CyCraft AIR offers comprehensive services including endpoint detection and response, network detection and response, operational global threat intelligence, and enterprise cyber-health assessments. By leveraging autonomous systems and human-AI collaboration, CyCraft aims to deliver efficient and effective cyber resilience solutions to a global audience.

Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

Fore Coffee is a specialty coffee shop based in Jakarta, Indonesia, founded in 2018. The company aims to transform coffee consumption through the integration of technology. Fore Coffee focuses on providing a distinctive experience by brewing each cup with freshly roasted Arabica beans, which are carefully sourced and blended to enhance flavor and strength. The emphasis on quality and innovation positions Fore Coffee as a notable player in the Indonesian coffee market.

Warung Pintar Group is a micro retail technology company focused on digitalizing grassroots businesses in Indonesia. The company aims to empower underserved communities by enhancing the quality of street stalls through innovative solutions. Warung Pintar offers smart kiosk stores that feature modern amenities such as digital point-of-sale systems, free Wi-Fi, LCD screens, and power bank chargers. By leveraging data processing and analysis, the company provides valuable insights for financial inclusion and community engagement, fostering opportunities for social security and behavior analysis. Additionally, Warung Pintar assists aspiring entrepreneurs in securing land and funding to establish new shops, ultimately contributing to local economic development and impact monitoring within the community.

17LIVE Inc. is a live streaming platform that operates primarily in Taiwan, Japan, South Korea, Singapore, and Hong Kong. Founded in 2015 and headquartered in New Taipei City, Taiwan, the company offers its live streaming services under the 17 Media brand. Additionally, it provides online dating services through its Paktor and Goodnight brands. The platform enables users to share their life experiences and talents in real-time, fostering social connections and community engagement. 17LIVE aims to facilitate instant audio and video communication, allowing users to connect with others globally, regardless of their location. The company, which was formerly known as M17 Entertainment Limited, rebranded to 17LIVE Inc. in October 2020.

Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

Warung Pintar Group is a micro retail technology company focused on digitalizing grassroots businesses in Indonesia. The company aims to empower underserved communities by enhancing the quality of street stalls through innovative solutions. Warung Pintar offers smart kiosk stores that feature modern amenities such as digital point-of-sale systems, free Wi-Fi, LCD screens, and power bank chargers. By leveraging data processing and analysis, the company provides valuable insights for financial inclusion and community engagement, fostering opportunities for social security and behavior analysis. Additionally, Warung Pintar assists aspiring entrepreneurs in securing land and funding to establish new shops, ultimately contributing to local economic development and impact monitoring within the community.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. The company employs an autologous ex vivo gene therapy approach, which aims to modify a patient's hematopoietic stem cells to create a personalized treatment through a single administration. Orchard's product portfolio includes Strimvelis, the first gene therapy approved by the European Medicines Agency for adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company is advancing several clinical programs, including OTL-101 for ADA-SCID, OTL-200 for metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Additionally, Orchard has a robust preclinical pipeline targeting various mucopolysaccharidosis types. Founded in 2015, Orchard Therapeutics collaborates with leading institutions in the field to enhance its research and development efforts.

Appier Inc., established in 2012 and headquartered in Taipei, Taiwan, specializes in providing AI-powered platforms for enterprises worldwide. Its suite of products includes Aideal for driving purchase decisions, AIQUA for proactive customer engagement, AIXON for unified data science, and CrossX for AI-driven advertising solutions. Appier serves approximately 1,000 global brands and agencies across Asia from its offices in 14 markets, helping businesses make data-driven decisions to increase customer engagement and predict user behavior without the need for specialized AI engineers.

SORACOM is a Tokyo-based company that specializes in providing an Internet of Things (IoT) platform designed to facilitate data communication for IoT and M2M (machine-to-machine) devices. The platform leverages scalable cloud technologies running on Amazon Web Services, enabling IoT solution developers to efficiently deploy and enhance their services while accommodating a variety of needs through flexible and customizable options. SORACOM enhances the security and reliability of data transfer across numerous devices and custom protocols, significantly reducing both time-to-market and costs associated with IoT services. Key offerings include SORACOM Air, which provides mobile data communication for IoT devices through its "Air SIM," allowing users to manage settings and monitor data traffic via a web console or API. Additionally, SORACOM Beam enables secure offloading of data from IoT devices to the cloud, ensuring high encryption and remote management capabilities without direct Internet exposure. Since its official launch in September 2015, SORACOM has positioned itself as a comprehensive provider of IoT solutions.

Ticket Monster Inc. is an e-commerce company in Korea today. In 2014, 70% of TMON’s transactions were completed on mobile devices and its customer base continued to expand into multiple age segments. The company operates in three key verticals - Goods, Local and Travel - and offers over 47,000 SKUs through partnerships with approximately 15,000 merchants.

Star 360 Holdings is a Singapore-based retailer specializing in sports and fashion footwear. The company offers a diverse range of products, including casual and formal footwear for men and women, running shoes, sandals, sneakers, and sports-specific shoes. In addition to footwear, Star 360 provides various accessories such as bags, wallets, and gym essentials like hydration products and masks. The company operates specialty stores and distributes its products globally, ensuring that customers have access to a wide selection of world-class brands tailored to their preferences.